K211840 is an FDA 510(k) clearance for the Sight OLO. This device is classified as a Counter, Differential Cell (Class II - Special Controls, product code GKZ).
Submitted by S.D. Sight Diagnostics , Ltd. (Tel Aviv, IL). The FDA issued a Cleared decision on May 9, 2022, 329 days after receiving the submission on June 14, 2021.
This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.5220.
| 510(k) Number | K211840 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | June 14, 2021 |
| Decision Date | May 09, 2022 |
| Days to Decision | 329 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | GKZ - Counter, Differential Cell |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 864.5220 |